NCT02461212View on ClinicalTrials.gov

Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

March 17, 2017

Study Completion Date

March 17, 2017

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
PROCEDURE

Magnetic Resonance Imaging (MRI)

A MRI scan which will include magnetic resonance spectroscopy (MRS) of the liver to determine hepatic triglyceride content, a hepafat scan to measure volume fraction of fat in liver tissue, and a MRI for detection of liver fibrosis. The scan will last approximately 15 minutes.

Trial Locations (1)

30322

Children's Healthcare of Atlanta at Egleston, Atlanta

All Listed Sponsors
collaborator

Resonance Health

INDUSTRY

lead

Emory University

OTHER

NCT02461212 - Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth | Biotech Hunter | Biotech Hunter